Johnson & Johnson

Johnson & Johnson shower lotion goods on supermarket shelves
URUMQI, XINJIANG UYGUR AUTONOMOUS REGION, CHINA - 2016/06/20: Johnson & Johnson shower lotion goods on supermarket shelves. Chinese consumer spending on fast moving consumer goods in the second quarter grew 4.6 percent from a year ago, up from 2 percent in the first quarter, according to a recent report. (Photo by Zhang Peng/LightRocket via Getty Images)Zhang Peng — LightRocket via Getty Images
  • Previous Rank
  • Revenues ($M)
  • Revenue Percent Change
  • Profits ($M)
  • Profits Percent Change
  • Assets ($M)
  • Employees
  • Market Value — as of March 31, 2017 ($M)

As the world's biggest health care products company, Johnson & Johnson has massive scope: a sampling of its products includes Benadryl, Band-Aids, Neutrogena, Tylenol, Motrin, and Listerine. How do you boost something that's already big? Acquisitions and revenue growth (notably in beauty products). While domestic sales rose 6%, international sales decreased about 1% thanks to divestitures, currency issues, and upheaval in Venezuela. Even if the international climate gets more comfortable, the company long known for its pioneering innovation could face competition from generics that could eat into sales.

Company Info

CEOAlex Gorsky
CEO TitleChairman & Chief Executive Officer
SectorHealth Care
HQ LocationNew Brunswick, NJ
Years on Fortune 500 List23

Key Financials (Last Fiscal Year)

Revenues ($M)$71,890
Profits ($M)$16,540
Assets ($M)$141,208
Total Stockholder Equity ($M)$70,418
Market Value — as of March 31, 2017 ($M)$337,642

Profit Ratios

Profit as % of Revenues23%
Profits as % of Assets11.7%
Profits as % of Stockholder Equity23.5%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)593
EPS % Change (from 2015)8.2%
EPS % Change (5 year annual rate)11.2%
EPS % Change (10 year annual rate)4.7%

Total Return

Total Return to Investors (2016)15.3%
Total Return to Investors (5 year, annualized)15.3%
Total Return to Investors (10 year, annualized)9%